Evidence map›Paper›PMID 37435066›Full record

ArticleFrontiers in immunology2023

Single-cell profiling reveals distinct immune response landscapes in tuberculous pleural effusion and non-TPE.

Xinting Yang, Jun Yan, Yu Xue, Qing Sun, Yun Zhang, Ru Guo, Chaohong Wang, Xuelian Li, Qingtao Liang, Hangyu Wu and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Xinting YangTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Jun YanDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Yu XueDepartment of Emergency, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Qing SunNational Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Yun ZhangTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Ru GuoTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Chaohong WangDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Xuelian LiTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Qingtao LiangTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Hangyu WuHeart Center, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Chong WangHeart Center, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Xinlei LiaoDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Sibo LongDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Maike ZhengDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Rongrong WeiBiobank, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Haoran ZhangBiobank, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Yi LiuBiobank, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Nanying CheBiobank, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Laurence Don Wai LuuSchool of Life Sciences, University of Technology Sydney, Sydney, Australia.
Junhua PanBeijing Chest Hospital, Capital Medical University, Beijing, China.
Guirong WangDepartment of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Yi WangExperimental Research Center, Capital Institute of Pediatrics, Beijing, China.
Capital Medical University · CNBeijing Chest Hospital · CNCapital Institute of Pediatrics · CNUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis (TB) is caused by Methods: We employed singe-cell RNA sequencing to 10 pleural fluid (PF) samples from 6 patients with TPE and 4 non-TPEs including 2 samples from patients with TSPE (transudative pleural effusion) and 2 samples with MPE (malignant pleural effusion). Result: Compared to TSPE and MPE, TPE displayed obvious difference in the abundance of major cell types (e.g., NK, CD4+T, Macrophages), which showed notable associations with disease type. Further analyses revealed that the CD4 lymphocyte population in TPE favored a Th1 and Th17 response. Tumor necrosis factors (TNF)-, and XIAP related factor 1 (XAF1)-pathways induced T cell apoptosis in patients with TPE. Immune exhaustion in NK cells was an important feature in TPE. Myeloid cells in TPE displayed stronger functional capacity for phagocytosis, antigen presentation and IFN-γ response, than TSPE and MPE. Systemic elevation of inflammatory response genes and pro-inflammatory cytokines were mainly driven by macrophages in patients with TPE. Conclusion: We provide a tissue immune landscape of PF immune cells, and revealed a distinct local immune response in TPE and non-TPE (TSPE and MPE). These findings will improve our understanding of local TB immunopathogenesis and provide potential targets for TB therapy.

Indexed as

Mycobacterium tuberculosisPleural EffusionTuberculosisAntigen PresentationHumansPleural Cavitylocal immune responseMycobacterium tuberculosisScRNA-seqtuberculosistuberculous pleural effusion

Identifiers

PMID37435066
PMCPMC10331301
OpenAlexW4382136230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.